Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effectiveness Of Atezolizumab Under Real-World Conditions In Patients With Locally-Advanced Or Metastatic Non-Small Cell Lung Cancer After Prior Chemotherapy

NCT03559647 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT03559647
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03559647 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effectiveness Of Atezolizumab Under Real-World Conditions In Patients With Locally-Advanced Or Metastatic Non-Small Cell Lung Cancer After Prior Chemotherapy
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
May 30, 2018
Completion date
August 20, 2023
Enrollment
358 (actual)
Sites
94

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer (nsclc)